← Back to Search

Decision-Making Skills for Adolescent Obesity (REACH Trial)

N/A
Waitlist Available
Led By Stephanie Manasse, Ph.D.
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial involves an online group program aimed at helping teenagers aged 14-18 with overweight or obesity lose weight. The program focuses on improving food choices by teaching better decision-making skills, especially for those who struggle with loss-of-control eating.

Who is the study for?
Adolescents aged 14-18 with obesity, defined as having a BMI between the 85th and 99th percentiles. Participants must have a smartphone, be willing to use an app and wear a fitness tracker for two weeks, and live at home in the US with parental involvement. Excluded are those on certain medications or with conditions affecting weight or ability to exercise.
What is being tested?
The study is looking into how decision-making affects dieting behaviors and weight loss success in overweight teens. It aims to identify key factors that should be included in future interventions targeting adolescent decision-making related to food choices.
What are the potential side effects?
Since this trial involves non-medical interventions like using apps and fitness trackers for monitoring diet and activity levels, there are no direct medical side effects. However, participants may experience stress or frustration related to lifestyle changes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Adolescent-specific behavioral weight loss treatmentExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Weight loss treatment
2007
Completed Phase 4
~260

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Binge Eating Disorder (BED) include cognitive-behavioral therapy (CBT) and behavioral weight loss therapy. CBT works by helping patients identify and change negative thought patterns and behaviors related to binge eating, fostering healthier coping mechanisms. Behavioral weight loss therapy focuses on altering eating and exercise habits to promote weight loss, which can reduce binge eating episodes. Both treatments emphasize self-monitoring, goal setting, and problem-solving skills, which are essential for managing eating behaviors effectively. These approaches are crucial for BED patients as they address the psychological and behavioral roots of the disorder, offering sustainable management strategies.
Psychotherapy outcome research with bulimia nervosa.First step in managing bulimia nervosa: controlled trial of therapeutic manual.The efficacy of self-help group treatment and therapist-led group treatment for binge eating disorder.

Find a Location

Who is running the clinical trial?

Drexel UniversityLead Sponsor
154 Previous Clinical Trials
48,143 Total Patients Enrolled
Stephanie Manasse, Ph.D.Principal InvestigatorDrexel University
1 Previous Clinical Trials
41 Total Patients Enrolled

Media Library

Weight loss treatment Clinical Trial Eligibility Overview. Trial Name: NCT04848532 — N/A
Impulsivity Research Study Groups: Adolescent-specific behavioral weight loss treatment
Impulsivity Clinical Trial 2023: Weight loss treatment Highlights & Side Effects. Trial Name: NCT04848532 — N/A
Weight loss treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT04848532 — N/A
~1 spots leftby Dec 2024